- Home
- AEON vs BMRA Comparison
AEON vs BMRA Comparison
Compare AEON & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEON
- BMRA
- Stock Information
- Founded
- AEON N/A
- BMRA 1971
- Country
- AEON United States
- BMRA United States
- Employees
- AEON N/A
- BMRA N/A
- Industry
- AEON Biotechnology: Pharmaceutical Preparations
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AEON Health Care
- BMRA Health Care
- Exchange
- AEON Nasdaq
- BMRA Nasdaq
- Market Cap
- AEON 8.0M
- BMRA 8.1M
- IPO Year
- AEON N/A
- BMRA N/A
- Fundamental
- Price
- AEON $0.64
- BMRA $3.04
- Analyst Decision
- AEON Strong Buy
- BMRA
- Analyst Count
- AEON 1
- BMRA 0
- Target Price
- AEON $360.00
- BMRA N/A
- AVG Volume (30 Days)
- AEON 104.9K
- BMRA 48.6K
- Earning Date
- AEON 08-19-2025
- BMRA 08-27-2025
- Dividend Yield
- AEON N/A
- BMRA N/A
- EPS Growth
- AEON N/A
- BMRA N/A
- EPS
- AEON 117.22
- BMRA N/A
- Revenue
- AEON N/A
- BMRA $5,678,000.00
- Revenue This Year
- AEON N/A
- BMRA N/A
- Revenue Next Year
- AEON N/A
- BMRA N/A
- P/E Ratio
- AEON $0.01
- BMRA N/A
- Revenue Growth
- AEON N/A
- BMRA 5.01
- 52 Week Low
- AEON $0.38
- BMRA $2.08
- 52 Week High
- AEON $115.57
- BMRA $10.16
- Technical
- Relative Strength Index (RSI)
- AEON 32.28
- BMRA 39.97
- Support Level
- AEON $0.70
- BMRA $3.07
- Resistance Level
- AEON $0.75
- BMRA $3.20
- Average True Range (ATR)
- AEON 0.05
- BMRA 0.26
- MACD
- AEON -0.01
- BMRA -0.06
- Stochastic Oscillator
- AEON 1.33
- BMRA 0.80
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.